Literature DB >> 16520017

The renal sequelae of a novel triphasic approach to blood loss reduction during hepatic resection.

S J Moug1, D Smith, I S Wilson, E Leen, P G Horgan.   

Abstract

AIMS: To report our novel triphasic approach to minimising blood loss during hepatic resection and the renal sequelae.
METHODS: Fifty consecutive patients (median age 63.3 years, range 37-86) underwent hepatic resection. Triphasic approach consisted of: pre-operative bowel preparation with no supplementary fluids; intraoperative intravenous fluid restriction with low central venous pressure (<5 cmH2O) and continuous selective occlusion of the left or right portal structures and corresponding hepatic vein/s. The following variables were analysed: blood loss; transfusion requirements; perioperative renal function; perioperative morbidity and mortality.
RESULTS: Median estimated blood loss was 330 mL (range 50-1200). No patient was transfused intraoperatively, with two patients transfused post-operatively. Median intraoperative urine output prior to hepatic re-perfusion was 28.4 mL/h (range 13.3-40.0) with no patient developing renal impairment. Morbidity occurred in 22% of patients with no documented hepatic failure. There was zero 30-day mortality.
CONCLUSIONS: Pre-operative dehydration and intraoperative fluid restriction combined with continuous selective vascular occlusion minimizes blood loss during hepatic resection with no consequent detriment to renal function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16520017     DOI: 10.1016/j.ejso.2006.01.011

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  2 in total

Review 1.  Systematic review of pathophysiological changes following hepatic resection.

Authors:  Joey Siu; John McCall; Saxon Connor
Journal:  HPB (Oxford)       Date:  2013-08-29       Impact factor: 3.647

2.  Rectal Sparing Approach After Neoadjuvant Therapy in Patients with Rectal Cancer: The Preliminary Results of the ReSARCh Trial.

Authors:  Francesco Marchegiani; Valeria Palatucci; Giulia Capelli; Mario Guerrieri; Claudio Belluco; Daniela Rega; Emilio Morpurgo; Claudio Coco; Angelo Restivo; Silvia De Franciscis; Carlo Aschele; Alessandro Perin; Michele Bonomo; Andrea Muratore; Antonino Spinelli; Salvatore Ramuscello; Francesca Bergamo; Giampaolo Montesi; Gaya Spolverato; Paola Del Bianco; Maria Antonietta Gambacorta; Paolo Delrio; Salvatore Pucciarelli
Journal:  Ann Surg Oncol       Date:  2021-12-02       Impact factor: 5.344

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.